122 related articles for article (PubMed ID: 31449888)
1. Incidence of occult malignancies identified during hysterectomies performed for benign indications.
Topdagi Yilmaz EP; Cimilli Senocak GN; Topdagi YE; Aynaoglu Yildiz G; Kumtepe Y
J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101620. PubMed ID: 31449888
[TBL] [Abstract][Full Text] [Related]
2. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications.
Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A
J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228
[TBL] [Abstract][Full Text] [Related]
3. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications.
Mahnert N; Morgan D; Campbell D; Johnston C; As-Sanie S
Obstet Gynecol; 2015 Feb; 125(2):397-405. PubMed ID: 25569001
[TBL] [Abstract][Full Text] [Related]
4. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
Kho KA; Lin K; Hechanova M; Richardson DL
Obstet Gynecol; 2016 Mar; 127(3):468-473. PubMed ID: 26855091
[TBL] [Abstract][Full Text] [Related]
5. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
Parsons LHP; Pedersen R; Richardson DL; Kho KA
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():108-112. PubMed ID: 29518640
[TBL] [Abstract][Full Text] [Related]
7. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications.
Ding Y; Han Y; Zhang S; Shi X
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4339-4345. PubMed ID: 36083311
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of unanticipated pathology in cases of hysterectomy for benign lesion a cross-section study in Al Shifa Medical Complex.
AbuSaqer SM; Shammala AIHA; Elejla S; Mahdi H; Laban RA; Hamada HA; Zimmo MW
Cancer Treat Res Commun; 2023; 35():100697. PubMed ID: 36989579
[TBL] [Abstract][Full Text] [Related]
11. Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease.
Wagner P; Kommoss FKF; Kommoss S; Hartkopf AD; Pasternak I; Oberlechner E; Greif K; Wallwiener M; Neis F; Abele H; Krämer B; Reisenauer C; Staebler A; Wallwiener D; Brucker SY; Taran FA
Gynecol Oncol; 2019 Apr; 153(1):49-54. PubMed ID: 30635214
[TBL] [Abstract][Full Text] [Related]
12. Alternative Treatment Utilization Before Hysterectomy for Benign Gynecologic Conditions at a Large Integrated Health System.
Nguyen NT; Merchant M; Ritterman Weintraub ML; Salyer C; Poceta J; Diaz L; Zaritsky EF
J Minim Invasive Gynecol; 2019; 26(5):847-855. PubMed ID: 30165183
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of occult uterine leiomyosarcomas.
Beyan E; Kanmaz AG; İnan AH; Karataşlı V; Tutar SO; Alan M; Töz E; Sancı M
Ginekol Pol; 2019; 90(8):433-437. PubMed ID: 31482545
[TBL] [Abstract][Full Text] [Related]
14. Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review.
Elliott CG; Murji A; Matelski J; Adekola AB; Chrzanowski J; Shirreff L
PLoS One; 2022; 17(4):e0266338. PubMed ID: 35363824
[TBL] [Abstract][Full Text] [Related]
15. Incidental finding of abnormal cervical pathology in hysterectomy specimens after normal preoperative Papanicolaou smears in Thammasat University Hospital.
Chundarat PA; Suwannarurk K; Bhamarapravatana K; Pattaraarchachai J; Thaweekul Y; Mairaing K; Poomtavorn Y
Asian Pac J Cancer Prev; 2014; 15(14):5811-4. PubMed ID: 25081705
[TBL] [Abstract][Full Text] [Related]
16. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
Mettler L; Abdusattarova K; Alkatout I
Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
[TBL] [Abstract][Full Text] [Related]
17. [Hysterectomy for benign lesions in the north of France: epidemiology and postoperative events].
Debodinance P
J Gynecol Obstet Biol Reprod (Paris); 2001 Apr; 30(2):151-9. PubMed ID: 11319467
[TBL] [Abstract][Full Text] [Related]
18. Risk of incidental genital tract malignancies at the time of myomectomy and hysterectomy for benign conditions.
Yadav G; Rao M; Goyal SB; Singh P; Kathuria P; Gothwal M
Obstet Gynecol Sci; 2021 Mar; 64(2):209-215. PubMed ID: 33321560
[TBL] [Abstract][Full Text] [Related]
19. The decline of hysterectomy for benign disease.
Horgan RP; Burke G
Ir Med J; 2009 Mar; 102(3):70, 72-3. PubMed ID: 19489192
[TBL] [Abstract][Full Text] [Related]
20. Indications of hysterectomy.
Thompson JD; Birch HW
Clin Obstet Gynecol; 1981 Dec; 24(4):1245-58. PubMed ID: 7333047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
